Card image cap

Mark DeSaulnier's Public Statements on Issue: Drugs

Office:

On The Ballot: Running, Democratic for U.S. House (CA) - District 10

Current Issue:

Drugs

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 2
Date Title
04/11/2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter
12/07/2021 Letter to Hon. Chuck Schumer, Majority Leader US Senate - Keep Affordable Insulin Measures in Build Back Better Act
08/06/2021 Letter to the Honorable Merrick Garland, Attorney General - Warren, Blumenthal, Maloney, and DeSaulnier Urge DOJ to Immediately Appeal Purdue Pharma's Bankruptcy Plan that Would Shield Sackler Family from Accountability for Opioid Crisis
03/19/2021 Maloney, DeSaulnier Introduce SACKLER Act to Prevent Bad Actors from Evading Responsibility Through Bankruptcy Proceedings
10/27/2020 Maloney and DeSaulnier Release Documents Following DOJ Settlement with Purdue and Sackler Family
01/23/2020 Letter to Alex Azar, Secretary of the Department of Health and Human Services - Lawmakers Call on Administration to Ban Flavored Vaping Products
11/06/2019 Congressman DeSaulnier Announces Legislation to Immediately Halt the Sale of E-Cigarettes Nationwide
03/28/2019 Letter to Chairwoman Rosa DeLauro and Ranking Member Tom Cole - Congressman Rose Leads Push to Increase Funding for Opioid Treatment, Prevention Efforts
03/21/2019 Representatives DeSaulnier and Cummings Seek Documents Relating to Sackler Family's Role in Fueling the Opioid Crisis
10/29/2018 Representatives DeSaulnier and Carter's Legislation to Curb Fraudulent Prescriptions Signed into Law as Part of Bipartisan, Bicameral Opioid Package
09/28/2018 Representatives DeSaulnier, Carter Pass Measure to Curb Fraudulent Prescriptions as Part of Bipartisan, Bicameral Opioid Package
07/02/2018 Letter to the Hon. Trey Gowdy, Chairman of the House Oversight and Government Reform Committee - Request Subpoena for Internal DOJ Report Indicating Purdue Pharma Concealed Knowledge of OxyContin Abuses
06/14/2018 Representatives DeSaulnier, Carter Pass Bipartisan Legislation to Curb Fraudulent Prescriptions of Opioids
06/12/2018 Letter to the Hon. Jeff Sessions, Attorney General, DOJ - Produce DOJ Report Showing Purdue Pharma Concealed Knowledge of OxyContin Abuses
05/24/2018 DeSaulnier Obtains Key Proposals to Fight Opioid Epidemic: Adds Three Provisions to ONDCP Bill to Reduce Doctor Shopping, Promote Evidence-Based Research, and Require Independent Audits
05/10/2018 Legislation to Fight Opioid Epidemic Authored by Representatives DeSaulnier and Carter Successfully Passes Out of Committee
04/19/2018 Letter to the Hon. John Culberson, House Subcommittee on Commerce, Justice, Science, and Related Agencies Chairman, and the Hon. José Serrano, Subcommittee Ranking Member - Effectively Address Opioid Crisis In Fiscal Year 2019 Spending Bill
03/16/2018 Letter to Rodney Frelinghuysen, Chairman of the House Appropriations Committee and Nita Lowey, Ranking Member of the House Appropriations Committee - Bipartisan Heroin Task Force Urges Congress to Protect ONDCP's Budget
03/15/2018 Letter to Rodney Frelinghuysen, Chairman of the House Appropriations Committee and Nita Lowey, Ranking Member of the House Appropriations Committee - Bipartisan Heroin Task Force Urges Congress to Expand CARA Funding
02/02/2018 Letter to the Honorable Paul Ryan, Speaker of the House of Representatives, the Honorable Nancy Pelosi, House Minority Leader, the Honorable Rodney Frelinghuysen, Chairman and the Honorable Nita Lowey, Ranking Member of House Appropriations Committee - Include Opioid Crisis Emergency Funding in Next Government Funding Bill
01/19/2018 Letter to President Donald Trump - Bipartisan Heroin Task Force Urges President to Renew Public Health Emergency Declaration and Provide Adequate Funding
01/19/2018 Letter to the Hon. Donald J. Trump, President of the United States - Declare Opioid Epidemic a National Emergency
12/11/2017 Letter to the Hon. Mick Mulvaney, Director of Office of Management and Budget - Additional Federal Opioid Relief
11/07/2017 Representatives DeSaulnier, Carter Introduce Bipartisan Legislation to Help Pharmacists Fight the Opioid Epidemic
08/22/2017 Letter to the Hon. Donald J. Trump, President - Implementation of Opioid Commission Recommendations
Page 1 of 2
arrow_upward